1. QC and correction for corrupted gradient directions in application to data of patients with hyperkinetic disorders
As an example for the effect of the application of QC and subsequent volume exclusion (as a consequence from the correction for corrupted GD), Figure 8 shows differences in whole brain based spatial statistics with and without volume exclusion for group comparison of 29 premanifest Huntington's disease subjects vs. 30 age and gender matched controls. The scanning protocol was performed on a 1.5 Tesla Magnetom Symphony (Siemens Medical, Erlangen, Germany). The DTI study protocol was identical for patients and controls and consisted of 72 volumes (40 slices, 96 x 96 pixels, slice thickness 2.3 mm, pixel size 2.3 x 2.3 mm), representing 64 gradient directions (b = 1,000 sec/mm2) and 8 scans with minimal diffusion weighting (b = 100 sec/mm2). The echo time (TE) and repetition time (TR) were 90 msec and 8,000 msec, respectively.
2. DTI in xeroderma pigmentosum
Xeroderma pigmentosum (XP) is a rare autosomal recessive progeroid syndrome where the underlying DNA repair defect plays a central role in the aging process 39,40. A multiparametric MRI approach to characterize the cerebromorphological phenotype was used in seven XP patients of different subtypes in order to assess the macrostructural and microstructural cerebral morphology in comparison to controls 41, including DTI, volumetric measurements, and MR spectroscopy (1H MRS).
The MRI protocol was acquired on a 1.5 Tesla MR system (Magnetom Symphony, Siemens, Erlangen, Germany), equipped with a standard headcoil. T1 weighted (T1w) scans consisted of 196 slices with a slice thickness of 1.0 mm (256 x 256 pixels, pixel size 1.0 x 1.0 mm). TE and TR were 12 msec and 456 msec, respectively. The DTI study protocol consisted of 13 volumes (45 slices, 128 x 128 pixels, slice thickness 2.2 mm, pixel size 1.5 x 1.5 mm), representing 12 gradient directions and one scan with gradient 0 (b = 0). TE and TR were 93 msec and 8,000 msec, respectively; b was 800 sec/mm2 and five scans were averaged online by the scanner software in image space.
Due to the clinical and demographic heterogeneity of the XP-subjects, the comparison was not performed at the group level but rather in a pairwise manner, i.e. each XP-subject was analyzed in comparison to an age- and gender matched control. FA-map comparison was performed for ROIs located in the thalamus, in the upper corticospinal tract, in the internal capsule, and in the corpus callosum. Furthermore, directionality changes were compared pairwise for FT and consecutive TFAS, with starting points in the thalamus. DTI demonstrated significantly reduced WM directionality in all regions investigated, i.e. the thalamus, the corticospinal tracts and the dorsal corpus callosum, with volume and directionality reductions of the fiber projections involving both the craniocaudal fibers and the interhemispheric connections (Figure 9). These findings, although heterogeneous among the study sample, could be correlated with the clinico-neurological symptoms. The imaging findings support the position that myelin structures degrade prematurely in the brain of XP patients, as discussed in 41.
DTI in neurodegeneration (motor neuron diseases)
Morphological changes in amyotrophic lateral sclerosis (ALS) patients by structural MRI analysis 42,43 as well as sensorimotor functional connectivity changes in ALS patients 21 have been reported recently. In this work, as an example for application of the analysis methods WBSS and TFAS, twenty ALS patients were investigated by multiparametric MRI. Severity of physical symptoms as measured with the revised ALS functional rating scale (ALS-FRS-R) was in the range of mild to moderate (35.9 ± 8.0), and none of the patients showed neuropsychological signs of frontotemporal dementia. As control group twenty age- and gender matched healthy controls were scanned.
The scanning protocol was performed on a 1.5 Tesla Magnetom Symphony (Siemens Medical, Erlangen, Germany). The DTI study protocol was identical for patients and controls and consisted of 13 volumes (45 slices, 128 x 128 pixels, slice thickness 2.2 mm, pixel size 1.5 x 1.5 mm), representing 12 gradient directions and one scan with gradient 0 (b = 0). TE and TR were 93 msec and 8,000 msec, respectively; b was 800 sec/mm2and five scans were averaged online by the scanner software in image space.
The results for the ALS group showed extensive FA reductions along large parts of the CST and the CC, in the latter including the segment III according to the Hofer and Frahm scheme 44 but reaching beyond to ventral and dorsal CC areas (Figure 6).The results for the ALS group showed extensive FA reductions along large parts of the CST and the CC, in the latter including the segment III according to the Hofer and Frahm scheme 44 but reaching beyond to ventral and dorsal CC areas (Figure 6).
A further example was the investigation of WM involvement patterns in other motor neuron diseases (MND), i.e. ALS, primary lateral sclerosis (PLS), and hereditary spastic paraparesis (HSP) subdivided into pure (pHSP) and complicated (cHSP), by use of a two-fold approach of DTI analysis: WBSS on FA-maps was complemented by FT results and subsequent TFAS. DTI-based comparisons of ALS and PLS samples have been described by other authors as well 45. The PLS group analysis showed a similar pattern of decreased FA along the CST anatomy while the CC involvement was marked but less extensive than in ALS and more restricted to segment III. The analysis in the pHSP sample demonstrated FA reductions in the CST which included more circumscribed areas within this structure whereas the CC alterations were, similar to the pattern observed in the ALS group, extended over large parts of the dorsal CC including the motor segment. Finally, the cHSP group showed the largest areas of decreased FA which accumulated to one large connected cluster including the complete CST structure and large dorsal and also ventral parts of the CC. In summary, the controlled DTI analysis in a total of 72 patients with different MND showed characteristic lesion patterns correlated with the involvement of distinct brain areas within the pathological processes of the different disease entities. For a detailed description and discussion, please refer to 22,28,46
3. DTI for longitudinal comparisons
As an example for application of DTI in longitudinal comparison, a 46-year-old patient with biopsy-proven anaplastic oligoastrocytoma WHO III° was scanned. After complete surgery, the patient received combined radio-/chemotherapy and 6 cycles of adjuvant chemotherapy.
DTI was acquired at 4 timepoints, i.e. before combined radio-/chemotherapy and 2, 5, and 9 months after radio-/chemotherapy in order to depict the status of the regional and global WM integrity in a longitudinal design.
The scanning protocol was performed on a 1.5 Tesla Magnetom Symphony (Siemens Medical, Erlangen, Germany). The DTI study protocol consisted of 52 volumes (64 slices, 128 x 128 pixels, slice thickness 2.8 mm, pixel size 2.0 x 2.0 mm), representing 48 gradient directions and four scans with gradient 0 (b = 0). TE and TR were 95 msec and 8,000 msec, respectively; b was 1,000 sec/mm2.
Figure 10 exemplarily displays differences in the FA-maps between the DTI scan after radio-/chemotherapy and DTI scan 7 months later, i.e. scans of timepoints 2 and 4. WBSS is performed according to section 1.3. with an FA threshold of 0.15, FDR corrected.

Figure 1. In DTI, a voxel represents the diffusion properties of several bundles of axons to calculate a diffusion tensor, illustrated as ellipsoid. For each voxel, the tensor information could be parameterized in fractional anisotropy (FA) maps or used for fiber tracking (FT).

Figure 2. Upper panel: After a quality check (QC) and the corresponding volume elimination (VE), DTI metrics, e.g. FA-maps could be calculated. In the next step, either stereotaxic normalization (left) allows for comparison at the group level (whole brain based spatial statistics - WBSS and/or tractwise fractional anisotropy statistics - TFAS) or stereotaxic alignment (right) allows for comparison of longitudinal FA-maps. These analyses either lead to differences at the group level (left) or detect longitudinal differences within single subject DTI data (right). Click here to view larger figure.

Figure 3. (a) Representative motion corrupted axial slice with reduced intensity which was detected by the QC algorithm. (b) The respective localization in the reconstructed sagittal volume, indicated by a white arrow. The motion corruption is also visually indicated by a relative intensity loss compared to adjacent axial slices. (c) By application of a threshold of 0.8 (red line) in total 17 gradient directions were detected for volume elimination. The black arrow indicates the volume of (a) and (b). (d) Volume elimination statistics (number of eliminated gradient directions - GD) for 29 presymptomatic Huntington's disease subjects (PS) and 30 controls.

Figure 4. Preservation of directional information during stereotaxic normalization. (a) rigid brain transformation by translation and rotation to align the basic coordinate frames. (b) linear deformation according to landmarks. The components of the Eigenvectors had to be adapted according to the linear deformation. (c) non-linear normalization equalizing non-linear brain shape differences. The 3-D vector shifts were different for each voxel leading to a separate transformation for each voxel of the 3-D voxel array in order to preserve the directional relations between Eigenvectors of neighbored voxels.

Figure 5. (a) Schematic example for an iterative template-specific MNI-normalization: after a 1st normalization step based on landmarks, by arithmetic averaging of DTI-data I0, first templates T1 ((b = 0) template and FA-template) were obtained. Subsequently, in an iterative procedure, normalized DTI-data I1 were obtained by non-linear normalization to the previously defined templates (T1). From these newly normalized DTI-data I1, new templates (T2) were derived which again could be used for normalization. This iterative process is stopped when a predefined coincidence (measure by correlation) between DTI-data and templates was reached. (b) Scheme for data pre-processing prior to whole brain-based spatial statistics (WBSS): FA-maps are calculated from normalized DTI data and a smoothing filter to the individual normalized FA-maps is applied. In a consecutive step, voxelwise statistical comparison between the patient groups and the corresponding control group is performed. After correction for multiple comparisons using the false-discovery-rate (FDR) algorithm and a clustering procedure for further reduction of the alpha error, results are displayed on a morphological background. Click here to view larger figure.

Figure 6. Results of the whole brain-based spatial statistics (WBSS) of ALS patients vs. controls. (a) Local maximum of decreased FA values in a sagittal, coronar and axial view (thresholded at p<0.01, corrected for multiple comparisons). (b) FT with starting points in the corticospinal tract used as basis for TFAS. (c) (animation 1): Group differences in FA-maps detected by whole brain based spatial statistics (WBSS) between a sample of ALS patients and matched controls in slicewise visualization. Click here to view larger figure.

Figure 7. (animation 2): Fiber tracking (FT) on group averaged data (controls) with starting points in the corpus callosum (left) and in the corticospinal tract (right). Click here to view larger figure.

Figure 8. Whole brain based spatial statistics before artifact correction (volume elimination - VE) (left) and after artifact correction (right), each corrected at p < 0.05, false discovery rate (FDR)). FA increase in cold colors, FA decrease in hot colors.

Figure 9. Multiparametric MRI for a subject with xeroderma pigmentosum (XP). Upper row: T1-weighted conventional MRI post contrast in coronar, sagittal, and axial view. Focus on a left-hemispheric contrast-enhanced lesion with perifocal edema within the frontoparietal white matter. Middle row: FA maps (display threshold 0.2) with the identical focus. Lower row: FT results with seed points in the thalamus - left: XP subject, right: average FT from 7 controls.

Figure 10. Patient with biopsy-proven anaplastic oligoastrocytoma WHO III° and complete surgery and combined radio-/chemotherapy and adjuvant chemotherapy. Longitudinal differences in FA-maps between two subsequent scans with a time interval of 7 months (FA difference 0.15, FDR corrected).